• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定前顶体蛋白酶结合蛋白sp32前体作为一种人类癌胚抗原。

Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.

作者信息

Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, Aoe M, Nakamura S, Higashi T, Hiraki A, Wada H, Kumon H, Old L J, Nakayama E

机构信息

Department of Immunology, Okayama University Medical School, Okayama 700-8558, Japan.

出版信息

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3282-7. doi: 10.1073/pnas.041625098.

DOI:10.1073/pnas.041625098
PMID:11248070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC30645/
Abstract

Serological expression cloning of antigens eliciting a humoral immune response to a syngeneic mouse sarcoma identified pem (mouse placenta and embryonic expression gene) as a new member of the cancer/testis family. To identify the human homologue of pem, mouse pem sequences and pem-related expressed sequence tags from human testis were used as PCR primers for amplification using human testis cDNA. However, rather than pem, another gene, designated OY-TES-1, was isolated and found to be the human homologue of proacrosin binding protein sp32 precursor originally identified in mouse, guinea pig, and pig. OY-TES-1 maps to chromosome 12p12-p13 and contains 10 exons. Southern blot analysis suggests the presence of two OY-TES-1-related genes in the human genome. In normal tissues, OY-TES-1 mRNA was expressed only in testis, whereas in malignant tissues, a variable proportion of a wide array of cancers, including bladder, breast, lung, liver, and colon cancers, expressed OY-TES-1. Serological survey of 362 cancer patients with a range of different cancers showed antibody to OY-TES-1 in 25 patients. No OY-TES-1 sera reactivity was found in 20 normal individuals. These findings indicate that OY-TES-1 is an additional member of the cancer/testis family of antigens and that OY-TES-1 is immunogenic in humans.

摘要

通过血清学表达克隆技术,鉴定出一种能引发对同基因小鼠肉瘤产生体液免疫反应的抗原,该抗原确定Pem(小鼠胎盘和胚胎表达基因)为癌症/睾丸抗原家族的新成员。为了鉴定Pem的人类同源物,使用小鼠Pem序列和来自人类睾丸的Pem相关表达序列标签作为PCR引物,以人类睾丸cDNA进行扩增。然而,分离得到的不是Pem,而是另一个名为OY-TES-1的基因,它被发现是最初在小鼠、豚鼠和猪中鉴定出的前顶体蛋白结合蛋白sp32前体的人类同源物。OY-TES-1定位于染色体12p12 - p13,包含10个外显子。Southern印迹分析表明人类基因组中存在两个与OY-TES-1相关的基因。在正常组织中,OY-TES-1 mRNA仅在睾丸中表达,而在恶性组织中,包括膀胱癌、乳腺癌、肺癌、肝癌和结肠癌在内的多种癌症中有不同比例表达OY-TES-1。对362例患有不同癌症的癌症患者进行的血清学调查显示,25例患者体内存在抗OY-TES-1抗体。在20名正常个体中未发现OY-TES-1血清反应性。这些发现表明OY-TES-1是癌症/睾丸抗原家族的另一个成员,并且OY-TES-1在人类中具有免疫原性。

相似文献

1
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.鉴定前顶体蛋白酶结合蛋白sp32前体作为一种人类癌胚抗原。
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3282-7. doi: 10.1073/pnas.041625098.
2
OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.OY-TES-1在上皮性卵巢癌中的表达及血清免疫反应性
Int J Oncol. 2006 Oct;29(4):903-10.
3
Identification of an HLA-A24-restricted OY-TES-1 epitope recognized by cytotoxic T-cells.鉴定一种被细胞毒性T细胞识别的HLA - A24限制性OY - TES - 1表位。
Microbiol Immunol. 2005;49(11):1009-16. doi: 10.1111/j.1348-0421.2005.tb03688.x.
4
Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.采用SEREX对BALB/C甲基胆蒽肉瘤Meth A进行血清学分析:一种癌/睾丸抗原的鉴定
Int J Cancer. 2000 Dec 15;88(6):845-51. doi: 10.1002/1097-0215(20001215)88:6<845::aid-ijc1>3.0.co;2-n.
5
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.通过用乳腺癌血清对睾丸文库进行血清学筛选来鉴定肿瘤限制性抗原NY-BR-1、SCP-1以及一种新的癌/睾丸样抗原NW-BR-3。
Cancer Immun. 2002 Jun 28;2:5.
6
CTp11, a novel member of the family of human cancer/testis antigens.CTp11,人类癌胚抗原家族的一个新成员。
Cancer Res. 1999 Dec 15;59(24):6223-9.
7
Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.癌-睾丸抗原和ING1肿瘤抑制基因产物是乳腺癌抗原:组织特异性ING1转录本及一个同源基因的特征分析
Cancer Res. 1999 Dec 15;59(24):6197-204.
8
Identification and characterization of a novel cancer/testis antigen gene CAGE.一种新型癌胚抗原基因CAGE的鉴定与特征分析
Biochem Biophys Res Commun. 2002 Apr 5;292(3):715-26. doi: 10.1006/bbrc.2002.6701.
9
Knockdown of OY-TES-1 by RNAi causes cell cycle arrest and migration decrease in bone marrow-derived mesenchymal stem cells.RNAi 敲低 OY-TES-1 导致骨髓间充质干细胞的细胞周期停滞和迁移减少。
Cell Biol Int. 2012 Oct 1;36(10):917-22. doi: 10.1042/CBI20120037.
10
Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.癌-睾丸抗原OY-TES-1在肝细胞癌中的表达及免疫原性
Curr Med Sci. 2020 Aug;40(4):719-728. doi: 10.1007/s11596-020-2241-x. Epub 2020 Aug 29.

引用本文的文献

1
The potential value of cancer-testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy.癌症睾丸抗原在卵巢癌中的潜在价值:预后标志物和免疫治疗靶点。
Immun Inflamm Dis. 2024 Jun;12(6):e1284. doi: 10.1002/iid3.1284.
2
Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23.预测和鉴定癌症睾丸抗原 CT23 中 HLA-A*0201 限制性表位。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2293299. doi: 10.1080/21645515.2023.2293299.
3
Expression and clinical importance of a newly discovered alternative splice variant of the gene for acrosin binding protein found in human brain tumors.在人脑肿瘤中发现的一种新的顶体蛋白酶结合蛋白基因可变剪接变体的表达及其临床意义。
Asian Biomed (Res Rev News). 2020 Dec 31;14(6):243-252. doi: 10.1515/abm-2020-0033. eCollection 2020 Dec.
4
Alternative splicing of acrosin binding protein RNA transcript and its potential contributions to innovative cancer therapy.顶体素结合蛋白RNA转录本的可变剪接及其对创新癌症治疗的潜在贡献。
Asian Biomed (Res Rev News). 2020 Dec 31;14(6):215-216. doi: 10.1515/abm-2020-0031. eCollection 2020 Dec.
5
Systems-Level Mapping of Cancer Testis Antigen 1b/a to Sarcoma Pathways Identifies Activated Ran Binding-2 E3 SUMO-Protein Ligase and Transducin-Like Enhancer Protein 1.癌胚抗原1b/a在肉瘤通路中的系统水平图谱鉴定出激活的Ran结合蛋白2 E3泛素样修饰蛋白连接酶和转导素样增强子蛋白1
Front Genet. 2022 May 18;13:834445. doi: 10.3389/fgene.2022.834445. eCollection 2022.
6
TRPC5OS induces tumorigenesis by increasing ENO1-mediated glucose uptake in breast cancer.TRPC5OS通过增加乳腺癌中ENO1介导的葡萄糖摄取诱导肿瘤发生。
Transl Oncol. 2022 Aug;22:101447. doi: 10.1016/j.tranon.2022.101447. Epub 2022 May 16.
7
Immunohistochemistry Study of OY-TES-1 Location in Fetal and Adult Human Tissues.免疫组织化学研究 OY-TES-1 在胎儿和成人人体组织中的定位。
J Healthc Eng. 2022 Apr 13;2022:7052830. doi: 10.1155/2022/7052830. eCollection 2022.
8
Proteomic Analysis of Intracellular and Membrane-Associated Fractions of Canine () Epididymal Spermatozoa and Sperm Structure Separation.犬附睾精子细胞内和膜相关组分的蛋白质组学分析及精子结构分离
Animals (Basel). 2022 Mar 18;12(6):772. doi: 10.3390/ani12060772.
9
Cancer-testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis.卵巢癌中癌症-睾丸抗原 ACRBP 的表达和血清免疫反应性与其预后的关系。
Immun Inflamm Dis. 2021 Dec;9(4):1759-1770. doi: 10.1002/iid3.534. Epub 2021 Sep 16.
10
Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma.表观遗传药物联合治疗通过上调肝细胞癌中ACRBP的表达增强T细胞的抗肿瘤活性。
Am J Transl Res. 2021 Jul 15;13(7):7591-7609. eCollection 2021.

本文引用的文献

1
Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.采用SEREX对BALB/C甲基胆蒽肉瘤Meth A进行血清学分析:一种癌/睾丸抗原的鉴定
Int J Cancer. 2000 Dec 15;88(6):845-51. doi: 10.1002/1097-0215(20001215)88:6<845::aid-ijc1>3.0.co;2-n.
2
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.监测任何 HLA I 类等位基因患者对 NY-ESO-1 的 T 细胞反应的策略。
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10917-22. doi: 10.1073/pnas.97.20.10917.
3
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.黑色素瘤患者中自然产生的人类淋巴细胞抗原A2限制的CD8 + T细胞对癌胚抗原NY - ESO - 1的反应。
Cancer Res. 2000 Aug 15;60(16):4499-506.
4
MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression.MAGE-B5、MAGE-B6、MAGE-C2和MAGE-C3:MAGE家族中具有肿瘤特异性表达的四个新成员。
Int J Cancer. 2000 Jul 1;87(1):55-60.
5
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.监测CD8 T细胞对NY-ESO-1的反应:体液免疫和细胞免疫反应的相关性
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4760-5. doi: 10.1073/pnas.97.9.4760.
6
Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9.癌-睾丸抗原在肺癌中的表达:将溴结构域睾丸特异性基因(BRDT)定义为一种新的癌-睾丸基因CT9。
Cancer Lett. 2000 Mar 31;150(2):155-64. doi: 10.1016/s0304-3835(99)00385-7.
7
CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.CT10:一种通过代表性差异分析鉴定出的、与CT7及黑素瘤相关抗原(MAGE)家族同源的新型癌-睾丸(CT)抗原。
Int J Cancer. 2000 Mar 1;85(5):726-32. doi: 10.1002/(sici)1097-0215(20000301)85:5<726::aid-ijc21>3.0.co;2-f.
8
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.鉴定由人类组织相容性抗原(HLA)-DRB4*0101-0103呈递、并被表达NY-ESO-1的黑色素瘤患者的CD4(+) T淋巴细胞识别的NY-ESO-1表位。
J Exp Med. 2000 Feb 21;191(4):625-30. doi: 10.1084/jem.191.4.625.
9
CTp11, a novel member of the family of human cancer/testis antigens.CTp11,人类癌胚抗原家族的一个新成员。
Cancer Res. 1999 Dec 15;59(24):6223-9.
10
Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen.克隆编码MHC II类限制性抗原的基因:突变的CDC27作为一种肿瘤抗原。
Science. 1999 May 21;284(5418):1351-4. doi: 10.1126/science.284.5418.1351.